Search results
Results from the WOW.Com Content Network
Sucralfate is used for the treatment of active duodenal ulcers not related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs), as the mechanism behind these ulcers is due to acid oversecretion. [1] It is not FDA approved for gastric ulcers, but is widely used because of evidence of efficacy. [10]
This list is focusing on the hazard linked to the agents. This means that the carcinogenic agents are capable of causing cancer, but this does not take their risk into account, which is the probability of causing a cancer given the level of exposure to this carcinogenic agent. [2] The list is uptodate as of January 2024. [3]
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
For premium support please call: 800-290-4726 more ways to reach us
Sucralose is about 600 times sweeter than sucrose (table sugar), [4] [5] 3 times as sweet as both aspartame and acesulfame potassium, and 2 times as sweet as sodium saccharin. [4] The commercial success of sucralose-based products stems from its favorable comparison to other low-calorie sweeteners in terms of taste, stability, and safety.
Need help? Call us! 800-290-4726 Login / Join. Mail
Routhenstein says that for sweeteners like aspartame, some studies have raised concerns about a link to cancer. However, the majority of research, including reviews by the Food and Drug ...